A new research study focused on the beneficiary effects of Vitamin D to lower the risk of diabetes. These studies are indicative of the fact that higher the concentration of vitamin D in the blood, lower is the risk of diabetes.

It follows that Vitamin D plays a vital role in treating the damaged beta cells of the pancreas. These beta cells are highly significant in production, storage and release of regulated levels of insulin hormone. Thus, the beneficiary effects of the Vitamin D will undoubtedly prove a boon to treat diabetes.

The moment beta cells become dysfunctional; they adversely affect the production of the insulin hormone. As now the body has lower levels of insulin, it faces difficulty in controlling the sugar content in the blood. If you delay seeking proper medical care, the levels of the sugar may go beyond the dangerous levels.

The Salk Institute researchers accomplish the current study on Vitamin D. The Salk Institute has its headquarters in the United States. The use of Vitamin D to treat diabetes is beyond expectations. The study involved the use of Vitamin D in the cells and the mouse models. It proved to be beneficial in treating the damaged beta cells. In addition to this, the study provides an insight into the gene regulation. The gene regulation might be helpful in treating other diseases including cancers.

What did the In vivo studies reveal?

The beta cells used in the research were obtained using the embryonic stem cells. The study highlights the fact that the compound, iBRD9 enhances the activation of the receptor of Vitamin D. The compound iBRD9 was coupled to the vitamin to facilitate the process of beta cell improvement.

A research associate from the Salk says, “This study started out by looking at the role of vitamin D in beta cells. Epidemiological studies in patients have suggested a correlation between high vitamin D concentrations in the blood and a lower risk of diabetes, but the underlying mechanism was not well understood.”

The study makes its way to the journal Cell.